US20120164751A1 - Rapid Test Apparatus - Google Patents

Rapid Test Apparatus Download PDF

Info

Publication number
US20120164751A1
US20120164751A1 US12/938,331 US93833110A US2012164751A1 US 20120164751 A1 US20120164751 A1 US 20120164751A1 US 93833110 A US93833110 A US 93833110A US 2012164751 A1 US2012164751 A1 US 2012164751A1
Authority
US
United States
Prior art keywords
test
sample
chamber
receiving chamber
reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/938,331
Inventor
Greg Liang
Yahong Liang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/938,331 priority Critical patent/US20120164751A1/en
Publication of US20120164751A1 publication Critical patent/US20120164751A1/en
Assigned to BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT reassignment BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: QUIDEL CORPORATION
Assigned to QUIDEL CORPORATION reassignment QUIDEL CORPORATION RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BANK OF AMERICA, N.A.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0038Devices for taking faeces samples; Faecal examination devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0663Whole sensors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0672Integrated piercing tool
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0848Specific forms of parts of containers
    • B01L2300/0854Double walls
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/06Valves, specific forms thereof
    • B01L2400/0633Valves, specific forms thereof with moving parts
    • B01L2400/0644Valves, specific forms thereof with moving parts rotary valves
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/06Valves, specific forms thereof
    • B01L2400/0677Valves, specific forms thereof phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers
    • B01L2400/0683Valves, specific forms thereof phase change valves; Meltable, freezing, dissolvable plugs; Destructible barriers mechanically breaking a wall or membrane within a channel or chamber
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5082Test tubes per se
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2575Volumetric liquid transfer

Definitions

  • the invention is in general directed to methods and devices for rapid testing of solid, semi-solid, or liquid specimens, such as stool, blood, urine, saliva, or swab specimens of the cervix, urethra, nostril, and throat, and for rapid testing of environmental samples.
  • test buffer a container separate from the test device used to detect the presence of a particular test substance.
  • a portion of the resulting sample solution is transferred to a second test location for reacting with a reagent to obtain a test result that indicates the presence or quantity of the test substance in the specimen.
  • a plastic tube is used to suspend the fecal specimen in a test buffer, which dissolves the blood components of the specimen.
  • a breakable part of the plastic tube is then severed and a portion of the sample solution is released from the tube to a second device, which is used to conduct an immunological hemoglobin test.
  • the test result is read at a test area of the test device.
  • test assemblies that may be used for rapid testing of solid, semi-solid, or liquid specimens.
  • a rapid test device for testing the presence of fecal occult blood.
  • feces sample collection, treatment, and testing are performed all in one device.
  • a test buffer is pre-stored in the device in a sample receiving chamber, and at least one rapid lateral flow test strip for detecting hemoglobin is stored in a separate test chamber, the test chamber.
  • a sampling stick is attached to the upper cap of the device for stool sample collection, and the feces specimen is transferred to the test buffer chamber using the sampling stick.
  • the device is then shaken to distribute the feces sample into the buffer, and the test is initiated by twisting a cap at the bottom of the device, allowing the sample solution to contact a lateral flow test strip.
  • the visual test result may then be read from the lateral flow test strip within about 5 minutes.
  • a test device comprising a test assembly, wherein the test assembly may be, for example, longitudinal, having an upper end, a lower end, a sample receiving chamber that has an opening at the upper end of the test assembly, a test chamber having an opening at the lower end of the test assembly and capable of receiving a reagent member from the opening, a base capable of being coupled to the opening of the test chamber and sealing the lower end of the test assembly with the reagent member inside the test chamber, and a means for liquid communication from the sample receiving chamber to the test chamber that exists when the base is attached to the test assembly containing the reagent member inside the test chamber.
  • the test assembly may be any form having various appropriate dimensions for specimen collection and testing, and may, for example, be in the form of a cup, or, for example, a tube.
  • the testing devices of the present invention, for example, the test assembly may be of any suitable material, including, for example, plastic, such as, for example, a plastic selected from the group consisting of polyethylene, polypropylene, polystyrene, polyvinyl, and acrylonitrile butadiene styrene.
  • a diagnostic testing device comprising a longitudinal test assembly having an upper end, a lower end, a sample receiving chamber that has an opening at the upper end of the test assembly, a test chamber having an opening at the lower end of the test assembly and capable of receiving a reagent member from the opening, a reagent member inside the test chamber, a base coupled to the opening of the test chamber, wherein the base seals the lower end of the test assembly with the reagent member inside the test chamber, and a means for liquid communication from the sample receiving chamber to the test chamber.
  • the method for using the test assembly to make a diagnostic testing device comprises introducing a reagent member capable of reacting with an assay sample and producing a signal indicating the presence or quantity of an analyte of the assay sample into the test chamber from the lower end of the test assembly and attaching the base to the lower end of the test chamber.
  • the method for using a testing device of the invention comprises introducing a sample solution into the sample receiving chamber, activating the sample communication means from the sample receiving chamber to the test chamber and reading the test result of the reagent member.
  • the test device of the invention may be used, for example, for testing analytes selected from a group of analytes consisting of but not limited to drugs of abuse, hormones, tumor markers, cardiac markers, infectious pathogens, and environmental pollutants.
  • the test sample solution is a solution, which is suspected of containing certain levels of the analyte.
  • Such sample solution is selected from a group of solutions including body fluids including urine, saliva, plasma or serum, blood, and spinal fluid.
  • the sample solution may also contain a treatment solution, such as water, pH or protein buffer.
  • a treatment solution such as water, pH or protein buffer.
  • dust or powders suspected of containing drugs, explosives, or infectious substances may be dissolved in water or a pH buffer solution for testing, using a device of the invention.
  • FIG. 1 is a side view of a device of the invention.
  • FIG. 2 is an exploded view of the same device of FIG. 1
  • FIG. 3 is a top view of a test assembly of the invention.
  • FIG. 4 is a bottom view of the same part of FIG. 3 .
  • FIG. 5 is an elevated perspective view of another device of the invention.
  • FIG. 6 is an exploded view of the same device of FIG. 5 .
  • FIG. 7 is an elevated perspective view of the sample device of FIG. 5 in a test position.
  • FIG. 8 is a perspective view of a device of the invention.
  • FIG. 9 is an exploded view of the same device of FIG. 8 .
  • FIG. 1 in conjunction with FIG. 2 through FIG. 4 , depicts a device of the invention.
  • the sample collection and testing device comprises a testing assembly 110 and a base 120 .
  • the test assembly 110 is longitudinal having wall 111 , upper end 112 , lower end 113 , and septum wall 114 separating the interior of the test assembly into two chambers, a sample receiving chamber 115 , and test chamber 116 .
  • the septum wall has a bottom section 117 that bends away from the exterior wall 111 and a top section 118 that connects to the exterior wall 111 .
  • the bottom section 117 of the septum wall comprises a hole 119 , a bottom opening of the sample receiving chamber.
  • the exterior wall has thread 109 on the interior side at the bottom end.
  • the base 120 comprises a handle section 121 , insert section 122 having thread 123 and plug 125 for sealing off the bottom opening of the sample receiving chamber. Rubber o-ring 124 around the insert section 122 serves as a sealant.
  • the reagent member 140 comprises a wick section 141 and a test area 142 comprising an assay reagent 143 .
  • a sample solution contacts the wick section of the reagent member, the sample solution wicks up the wick section to the test area and reacts with the reagent. As a result, the presence or quantity of the test substance in the sample solution is detected.
  • a rubber o-ring 126 is provided as a sealant that closes the hole 119 .
  • Optional cap 130 comprises handle 131 , and sampler pin 132 .
  • the base is capable of tightly fitting to the bottom end of the test assembly, sealing off the bottom end of the test assembly, with the plug 125 and the o-ring 126 capable of sealing off the bottom opening of the sample receiving chamber;
  • the base 120 When a sample solution is introduced into the sample receiving chamber, loosening the base 120 opens up the plug 125 and the o-ring 126 from the hole 119 and allows the sample solution to flow through the hole 119 and contact the reagent member 140 of the test chamber 116 .
  • the assay result of the sample solution, on the assay reagent member 140 can be read through the wall 111 at the test chamber section.
  • a sample solution can be kept inside, or stored, inside the sample receiving chamber for future testing.
  • a sample solution may be prepared, and the test conducted at a later time.
  • a patient may obtain a sample and the device may then be given to a laboratory technician, or other trained personnel for conducting he test and interpreting the results.
  • a buffer solution for treating or diluting a test sample can be kept inside the sample receiving chamber before the sample is introduced into the sample receiving chamber.
  • the plug 125 or o-ring of the base 120 can be omitted from the device or the base be kept loose so that the passage between the sample receiving chamber and the test chamber is kept open.
  • a volume of the sample solution automatically flows from the sample receiving chamber into the test chamber through the sample passage or hole at the bottom section of the test assembly.
  • the optional cap 130 seals off the top opening of the sample receiving chamber. Its optional sampler pin is capable of collecting liquid or non-liquid samples and introducing the sample into the sample receiving chamber.
  • Liquid samples include, for example, but are not limited to, blood, urine, saliva, water, mucus, or other fluid samples.
  • Non-liquid samples include, for example, powder, stool, dirt, dust, and other dry or semi-dry samples.
  • test assembly of the invention wherein the hole 119 is sealed or plugged, comprising a pin or other sharp edge or protrusion connected to the top surface of the base that is capable of breaking the seal or removing the plug when the base is turned or pushed against the test assembly.
  • the sample solution flows through the hole once the seat is broken or plug is removed, or, in another embodiment, the solution flows through the hole after the seal is broken of plug removed.
  • the hole is sealed when the cap is loosely fitted, and is unsealed when the cap is tightened, breaking the seal with the pin.
  • FIG. 5 in conjunction with FIG. 6 and FIG. 7 , depicts another embodiment of the present invention.
  • Device 200 comprises a test assembly 201 comprising an upper end 202 and a lower end 203 , a sample receiving chamber 204 comprising a test buffer 205 and a test chamber 206 comprising a reagent member 207 .
  • a bottom part 208 closes the lower end of the test assembly 201
  • a cap 209 closes the upper end of the test assembly
  • a means, such as a pincap 210 is provided for enabling liquid flow from the sample receiving chamber 204 to the test chamber 206 .
  • the test assembly 201 comprises a plastic tube structure comprising a tubular interior wall 211 and exterior wall 212 that join together at the neck area 227 .
  • the double layer sidewall forms an interior sample receiving chamber 204 and a test chamber 206 .
  • a breakable seal 213 seals off the lower end opening of the interior wall 211 .
  • the bottom part 208 sized to fit the lower end of the test assembly seals off the test assembly 206 from the lower end.
  • the bottom part 208 comprises an upper end 214 and lower end 215 , a sidewall 216 for fitting to the interior of the lower end of the test assembly, and a through hole 217 sealed off by a breakable seal 218 at the upper end 214 .
  • the pincap 210 comprises a rod 219 sized to fit into the through hole 217 of the bottom part and capable of breaking the breakable seals 218 and 213 when forced into the through hole from the lower end of the through hole.
  • the cap 209 comprises a handle section 220 and an insert section 221 sized to fit to the upper opening 202 of the test assembly and closes the upper end of the assembly.
  • the reagent member 207 comprises an upper end 222 and lower end 223 , a test area 224 proximal to the upper end 222 and a wick section 225 proximal to the lower end 223 .
  • the test area comprises at least one reagent 226 .
  • a liquid in contact with the wick section 225 is capable of wicking through the wick section to the test area 224 and contacting the reagent 226 .
  • the reagent member is disposed inside the test chamber with the upper end oriented towards the upper end of the test assembly and with the lower end of the reagent member oriented to the lower end of the test assembly.
  • the breakable seals of the test assembly are a hydrophobic barrier selected from a group consisting of plastic, rubber, and foil, attached to the sidewall of the sample receiving chamber.
  • the seal breaking means for breaking the breakable seal includes any means capable of penetrating, tearing, or removing a portion of the breakable seal when the device is in a test position.
  • the seal breaking means is a stick inserted from the upper end of the sample receiving chamber capable of breaking the seal.
  • the stick in exemplary embodiments, is designed to be sanitary, that is, to not contaminate the specimen or sample solution.
  • the seal breaking means is a structure attached to the test module container capable of breaking the seal from the lower end of the sample receiving chamber.
  • FIG. 8 depicts a device of another embodiment of the invention.
  • the device 300 comprises an assembly 310 comprising a cup shaped transparent part 311 having an exterior wall or side wall 312 , upper opening 313 , lower opening 314 , and a septum 315 .
  • the septum 315 is connected to the side wall 312 and separates the cup interior into an upper section 316 and a lower section 317 connected through a through-hole 318 .
  • a septum comprises a section 319 that is at an angle with the side wall and another section 320 that bends upward to form a pocket 321 , a reagent member receptacle, with the side wall.
  • the reagent member receptacle 321 contains a reagent member, an absorbent test strip comprising a wick section 331 , a test area 332 comprising a reagent 333 .
  • a bottom part 340 is sized to fit to the lower opening of the cup part with the reagent member inside the reagent member receptacle.
  • a vent hole 341 is a through hole of the bottom part 340 .
  • a porous plug 342 that is air permeable and sample solution impermeable fills in the through hole 341 .
  • An optional cap 350 is sized properly to fit to the upper opening 311
  • the porous plug comprises a porous material of the desired property—air permeable and sample solution impermeable.
  • a porous material of the desired property air permeable and sample solution impermeable.
  • materials that may be used to form the porous plastic plug such as, for example, but not limited to, polyethylene and polytetrafluoroethylene.
  • the median pore size in the porous plastic plug may range from 3 microns to an upper limit which is dependent on the hydrophobicity of the plug material.
  • Air and liquid permeability of porous plugs is related to the pore size and the surface property of the porous material.
  • the pore size of the plug is generally smaller than 30 microns, for example, 10-20 microns.
  • Coating the surface of the porous material with a layer that will melt and forms a gel upon contact with the sample solution is another way to achieve the desired property.
  • Such gel forming material can be selected from a group consisting gum, gelatin, long change polysaccharides, and proteins.
  • the reagent member may comprise more than one test reagent for detecting more than one test substance in the sample solution.
  • the device 300 may contain more than one absorbent test strip each for detecting a different test substance, such as a drug of abuse.
  • a sample solution such as a urine specimen
  • the samples flows to the lower section of the device and reacts with the reagents. Therefore, multiple test substances, such as drugs of abuse, can be detected simultaneously.
  • the liquid level in the lower section of the device reaches the porous plug, the air vent through the plug closes. Additional liquid flow from the upper section to the lower section stops.
  • Such a mechanism forms an automatic control of the volume of liquid flows into the test chamber.
  • the devices of the invention can be used, for example, for testing body fluid samples, environmental samples, stool, and other samples. Substances can be tested using the devices of the invention include drugs of abuse, therapeutic drugs, infectious pathogens, antibodies, blood components, environmental pollutants, such as micro-organisms, explosives, and poisons.
  • the devices of the invention are suitable for testing specimens selected, for example, from the group consisting of stool, blood, urine, and saliva, microbe culture media, and swab specimens of surfaces of an animal, such as the cervix, urethra, nostril, and throat, as well as environmental specimens, such as food products, soil and dust samples.
  • animal is meant, for example, any live or dead animal including, for example, a mammal, for example, a human.
  • Substances to be tested in these specimens include but are not limited to fecal occult blood components, hapto-hemoglobin complex, antibodies, bacteria, viruses, enzymes, proteins, drugs, substances of abuse, allergens, pesticides, and pollutants.
  • the reagent member can be in liquid, or dry form.
  • the reagent member of the test device is a liquid solution comprising reagents capable of reacting with analytes of the sample solution to be tested and produce an assay signal indicative of the presence or quantity of at least one analytes of the sample solution.
  • the assay reagent is a dry reagent comprising reagents capable of reacting with analytes of the sample solution to be tested and produce an assay signal indicative of the presence or quantity of at least one analytes of the sample solution. Dry reagents, air-dried or lyophilized, have longer shelf life than liquid reagents.
  • a preferred dry form of assay reagent is, for example, but not limited to, a dry reagent pad, a porous matrix containing the dry assay reagent.
  • Such dry reagents are used for a variety of testing products, such as urine glucose, pH, creatinine, and alcohol test.
  • Another example of a preferred dry reagent member is a lateral flow test strip.
  • the reagent member is a dry reagent, for example, a test strip
  • the test assembly may comprise more than 1 reagent member, for example, each reagent member comprising reagents for a different analyze detection assay.
  • a device for fecal occult blood test may comprise a reagent member for detecting hemoglobin and another reagent member for detecting hapto-hemoglobin complex.
  • kits for detecting test substances in solid, semi-solid, or liquid specimens are provided.
  • kits that comprise a device of he present invention may further comprise instructions for testing for the presence of a substance in a specimen, and may further comprise instructions for obtaining specimen samples.
  • the kits may further comprise reference samples that may be used to compare test results with the specimen samples.
  • a fecal occult blood test is an immunoassay based test method for detection of blood in stool specimens.
  • the presence of hemoglobin in feces can be indicative of gastrointestinal tract conditions associated with bleeding such as, for example, colorectal carcinoma, colon polyps, Crohn's disease, and ulcerative colitis.
  • the present example provides a 2-in-1 sample preparation and test device, that does not require liquid pipetting or transfer of the sample or sample solution.
  • a fecal sample is collected and prepared for testing using the fecal collection probe, or sample stick, attached to the cap of the test assembly of the invention. The collection probe is inserted into a fecal specimen at several different sites. Excess sample is removed from the stick by gentle wiping with an absorbent tissue.
  • the probe is reinserted into the tube and the cap is tightened securely.
  • the tube is shaken vigorously to obtain a liquid suspension of the sample. Holding the tube upright, the bottom part of the chamber assembly is loosened about 1 revolution (360°). This allows the sample solution inside of the sample receiving chamber to flow into the test chamber.
  • the device is kept in an upright position for 5 minutes, after which time the results may be read. Waiting for more than 10 minutes may cause the reading to be inaccurate.
  • a negative test is indicated when one rose-pink color band appears in the control zone, meaning that the fecal sample does not contain a detectable level of human hemoglobin.
  • a positive test is indicated when two rose-pink color bands appear, one in the test (T) zone and one in the control (c) zone, A positive result indicates that the specimen contains human hemoglobin.
  • An invalid test is indicated where after five minutes, no bands appear, or a test band appears without a control band appearing.
  • a subset includes a plurality of such subsets.
  • Reference to “a nucleic acid” includes one or more nucleic acids and equivalents thereof known to those skilled in the art, and so forth.
  • the term “or” is not meant to be exclusive to one or the terms it designates. For example, as it is used in a phrase of the structure “A or B” may denote A alone, B alone, or both A and B.

Abstract

Provided herein are methods and devices for rapid testing of solid, semi-solid, or liquid specimens, such a stool, blood, urine, saliva, or swab specimens of the cervix, urethra, nostril, throat, and for environmental testing.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 11/625,813 filed Jan. 22, 2007, now allowed, which claims the benefit of priority to U.S. Provisional Application No. 60/761,580, filed Jan. 23, 2006, each of which is incorporated by reference in their entirely herein.
  • TECHNICAL FIELD
  • The invention is in general directed to methods and devices for rapid testing of solid, semi-solid, or liquid specimens, such as stool, blood, urine, saliva, or swab specimens of the cervix, urethra, nostril, and throat, and for rapid testing of environmental samples.
  • BACKGROUND
  • The testing of solid, semi-solid, or liquid specimens such as stool, blood, urine, saliva, or swab specimens of the cervix, urethra, nostril, or throat, as well as environmental specimens, such as food products, soil and dust, often requires pre-treating the specimens with a test buffer, Pre-treating the specimens helps to dilute the specimen, extract substances to be detected from the specimen, or alter the specimen or substances. This pre-treatment results in a new sample solution that is more suitable for the test substance to be detected. Typically, the collected specimen is pre-mixed with the test buffer in a container separate from the test device used to detect the presence of a particular test substance. In most testing protocols, a portion of the resulting sample solution is transferred to a second test location for reacting with a reagent to obtain a test result that indicates the presence or quantity of the test substance in the specimen. For example, in a fecal occult blood test, a plastic tube is used to suspend the fecal specimen in a test buffer, which dissolves the blood components of the specimen. A breakable part of the plastic tube is then severed and a portion of the sample solution is released from the tube to a second device, which is used to conduct an immunological hemoglobin test. The test result is read at a test area of the test device.
  • The procedures for severing the specimen treatment tube and transferring the sample solution from the specimen treatment tube to the test device complicates the test methods by requiring multiple steps. By requiring that the sample be transferred, the work area may be contaminated due to sample leakage. Also, transferring the sample solution may lead to inaccurate results because of the possible transfer of inaccurate test volumes. These methods are not convenient for onsite testing by non-laboratory trained users. What is needed is a more simple, safe, and accurate method of testing of solid, semi-solid, or liquid specimens.
  • SUMMARY
  • The present invention provides devices and methods for treating and testing specimens that are simpler, safer to use, and more accurate. In certain embodiments of the present invention are provided test assemblies that may be used for rapid testing of solid, semi-solid, or liquid specimens. In one non-limiting embodiment is provided a rapid test device for testing the presence of fecal occult blood. In this embodiment of the invention, feces sample collection, treatment, and testing are performed all in one device. For example, a test buffer is pre-stored in the device in a sample receiving chamber, and at least one rapid lateral flow test strip for detecting hemoglobin is stored in a separate test chamber, the test chamber. A sampling stick is attached to the upper cap of the device for stool sample collection, and the feces specimen is transferred to the test buffer chamber using the sampling stick. The device is then shaken to distribute the feces sample into the buffer, and the test is initiated by twisting a cap at the bottom of the device, allowing the sample solution to contact a lateral flow test strip. The visual test result may then be read from the lateral flow test strip within about 5 minutes.
  • In one embodiment is provided a test device comprising a test assembly, wherein the test assembly may be, for example, longitudinal, having an upper end, a lower end, a sample receiving chamber that has an opening at the upper end of the test assembly, a test chamber having an opening at the lower end of the test assembly and capable of receiving a reagent member from the opening, a base capable of being coupled to the opening of the test chamber and sealing the lower end of the test assembly with the reagent member inside the test chamber, and a means for liquid communication from the sample receiving chamber to the test chamber that exists when the base is attached to the test assembly containing the reagent member inside the test chamber. The test assembly may be any form having various appropriate dimensions for specimen collection and testing, and may, for example, be in the form of a cup, or, for example, a tube. The testing devices of the present invention, for example, the test assembly, may be of any suitable material, including, for example, plastic, such as, for example, a plastic selected from the group consisting of polyethylene, polypropylene, polystyrene, polyvinyl, and acrylonitrile butadiene styrene.
  • Also disclosed is a diagnostic testing device comprising a longitudinal test assembly having an upper end, a lower end, a sample receiving chamber that has an opening at the upper end of the test assembly, a test chamber having an opening at the lower end of the test assembly and capable of receiving a reagent member from the opening, a reagent member inside the test chamber, a base coupled to the opening of the test chamber, wherein the base seals the lower end of the test assembly with the reagent member inside the test chamber, and a means for liquid communication from the sample receiving chamber to the test chamber.
  • The method for using the test assembly to make a diagnostic testing device comprises introducing a reagent member capable of reacting with an assay sample and producing a signal indicating the presence or quantity of an analyte of the assay sample into the test chamber from the lower end of the test assembly and attaching the base to the lower end of the test chamber.
  • The method for using a testing device of the invention comprises introducing a sample solution into the sample receiving chamber, activating the sample communication means from the sample receiving chamber to the test chamber and reading the test result of the reagent member.
  • The test device of the invention may be used, for example, for testing analytes selected from a group of analytes consisting of but not limited to drugs of abuse, hormones, tumor markers, cardiac markers, infectious pathogens, and environmental pollutants. The test sample solution is a solution, which is suspected of containing certain levels of the analyte. Such sample solution is selected from a group of solutions including body fluids including urine, saliva, plasma or serum, blood, and spinal fluid. The sample solution may also contain a treatment solution, such as water, pH or protein buffer. For example, dust or powders suspected of containing drugs, explosives, or infectious substances may be dissolved in water or a pH buffer solution for testing, using a device of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a side view of a device of the invention.
  • FIG. 2 is an exploded view of the same device of FIG. 1
  • FIG. 3 is a top view of a test assembly of the invention.
  • FIG. 4 is a bottom view of the same part of FIG. 3.
  • FIG. 5 is an elevated perspective view of another device of the invention.
  • FIG. 6 is an exploded view of the same device of FIG. 5.
  • FIG. 7 is an elevated perspective view of the sample device of FIG. 5 in a test position.
  • FIG. 8 is a perspective view of a device of the invention.
  • FIG. 9 is an exploded view of the same device of FIG. 8.
  • DETAILED DESCRIPTION
  • FIG. 1, in conjunction with FIG. 2 through FIG. 4, depicts a device of the invention. The sample collection and testing device comprises a testing assembly 110 and a base 120.
  • The test assembly 110 is longitudinal having wall 111, upper end 112, lower end 113, and septum wall 114 separating the interior of the test assembly into two chambers, a sample receiving chamber 115, and test chamber 116. The septum wall has a bottom section 117 that bends away from the exterior wall 111 and a top section 118 that connects to the exterior wall 111. The bottom section 117 of the septum wall comprises a hole 119, a bottom opening of the sample receiving chamber. The exterior wall has thread 109 on the interior side at the bottom end.
  • The base 120 comprises a handle section 121, insert section 122 having thread 123 and plug 125 for sealing off the bottom opening of the sample receiving chamber. Rubber o-ring 124 around the insert section 122 serves as a sealant.
  • In this embodiment, The reagent member 140 comprises a wick section 141 and a test area 142 comprising an assay reagent 143. When a sample solution contacts the wick section of the reagent member, the sample solution wicks up the wick section to the test area and reacts with the reagent. As a result, the presence or quantity of the test substance in the sample solution is detected.
  • A rubber o-ring 126 is provided as a sealant that closes the hole 119.
  • Optional cap 130 comprises handle 131, and sampler pin 132.
  • With an assay reagent member 140 inserted in the test chamber 116, the base is capable of tightly fitting to the bottom end of the test assembly, sealing off the bottom end of the test assembly, with the plug 125 and the o-ring 126 capable of sealing off the bottom opening of the sample receiving chamber;
  • When a sample solution is introduced into the sample receiving chamber, loosening the base 120 opens up the plug 125 and the o-ring 126 from the hole 119 and allows the sample solution to flow through the hole 119 and contact the reagent member 140 of the test chamber 116. The assay result of the sample solution, on the assay reagent member 140, can be read through the wall 111 at the test chamber section.
  • There are several options for this device to adapt to specific needs. First, with the reagent member inserted inside the test chamber, the base fitting into the bottom end of the test assembly with the plug 125 sealing off the bottom opening of the sample receiving chamber, a sample solution can be kept inside, or stored, inside the sample receiving chamber for future testing. Thus, a sample solution may be prepared, and the test conducted at a later time. For example, a patient may obtain a sample and the device may then be given to a laboratory technician, or other trained personnel for conducting he test and interpreting the results. Alternatively, a buffer solution for treating or diluting a test sample can be kept inside the sample receiving chamber before the sample is introduced into the sample receiving chamber. Secondly, the plug 125 or o-ring of the base 120 can be omitted from the device or the base be kept loose so that the passage between the sample receiving chamber and the test chamber is kept open. When a sample solution is introduced into the sample receiving chamber, a volume of the sample solution automatically flows from the sample receiving chamber into the test chamber through the sample passage or hole at the bottom section of the test assembly.
  • The optional cap 130 seals off the top opening of the sample receiving chamber. Its optional sampler pin is capable of collecting liquid or non-liquid samples and introducing the sample into the sample receiving chamber. Liquid samples include, for example, but are not limited to, blood, urine, saliva, water, mucus, or other fluid samples. Non-liquid samples include, for example, powder, stool, dirt, dust, and other dry or semi-dry samples.
  • Other means for permitting liquid communication from the sample-receiving chamber to the test chamber may be employed in the device. For example, simple modification to the device of FIG. 1 is, in one embodiment, a test assembly of the invention wherein the hole 119 is sealed or plugged, comprising a pin or other sharp edge or protrusion connected to the top surface of the base that is capable of breaking the seal or removing the plug when the base is turned or pushed against the test assembly. In this embodiment, the sample solution flows through the hole once the seat is broken or plug is removed, or, in another embodiment, the solution flows through the hole after the seal is broken of plug removed. In this embodiment, in one example, the hole is sealed when the cap is loosely fitted, and is unsealed when the cap is tightened, breaking the seal with the pin.
  • FIG. 5, in conjunction with FIG. 6 and FIG. 7, depicts another embodiment of the present invention. Device 200 comprises a test assembly 201 comprising an upper end 202 and a lower end 203, a sample receiving chamber 204 comprising a test buffer 205 and a test chamber 206 comprising a reagent member 207. A bottom part 208 closes the lower end of the test assembly 201, a cap 209 closes the upper end of the test assembly, and a means, such as a pincap 210 is provided for enabling liquid flow from the sample receiving chamber 204 to the test chamber 206. The test assembly 201 comprises a plastic tube structure comprising a tubular interior wall 211 and exterior wall 212 that join together at the neck area 227. The double layer sidewall forms an interior sample receiving chamber 204 and a test chamber 206. A breakable seal 213 seals off the lower end opening of the interior wall 211. The bottom part 208 sized to fit the lower end of the test assembly seals off the test assembly 206 from the lower end. The bottom part 208 comprises an upper end 214 and lower end 215, a sidewall 216 for fitting to the interior of the lower end of the test assembly, and a through hole 217 sealed off by a breakable seal 218 at the upper end 214. The pincap 210 comprises a rod 219 sized to fit into the through hole 217 of the bottom part and capable of breaking the breakable seals 218 and 213 when forced into the through hole from the lower end of the through hole. The cap 209 comprises a handle section 220 and an insert section 221 sized to fit to the upper opening 202 of the test assembly and closes the upper end of the assembly.
  • The reagent member 207 comprises an upper end 222 and lower end 223, a test area 224 proximal to the upper end 222 and a wick section 225 proximal to the lower end 223. The test area comprises at least one reagent 226. A liquid in contact with the wick section 225 is capable of wicking through the wick section to the test area 224 and contacting the reagent 226. The reagent member is disposed inside the test chamber with the upper end oriented towards the upper end of the test assembly and with the lower end of the reagent member oriented to the lower end of the test assembly.
  • The breakable seals of the test assembly are a hydrophobic barrier selected from a group consisting of plastic, rubber, and foil, attached to the sidewall of the sample receiving chamber. The seal breaking means for breaking the breakable seal includes any means capable of penetrating, tearing, or removing a portion of the breakable seal when the device is in a test position. In an embodiment of the invention, the seal breaking means is a stick inserted from the upper end of the sample receiving chamber capable of breaking the seal. The stick, in exemplary embodiments, is designed to be sanitary, that is, to not contaminate the specimen or sample solution. In another embodiment of the invention, the seal breaking means is a structure attached to the test module container capable of breaking the seal from the lower end of the sample receiving chamber.
  • FIG. 8, in conjunction with FIG. 9, depicts a device of another embodiment of the invention. The device 300 comprises an assembly 310 comprising a cup shaped transparent part 311 having an exterior wall or side wall 312, upper opening 313, lower opening 314, and a septum 315. The septum 315 is connected to the side wall 312 and separates the cup interior into an upper section 316 and a lower section 317 connected through a through-hole 318. A septum comprises a section 319 that is at an angle with the side wall and another section 320 that bends upward to form a pocket 321, a reagent member receptacle, with the side wall. The reagent member receptacle 321 contains a reagent member, an absorbent test strip comprising a wick section 331, a test area 332 comprising a reagent 333. A bottom part 340 is sized to fit to the lower opening of the cup part with the reagent member inside the reagent member receptacle. A vent hole 341 is a through hole of the bottom part 340. A porous plug 342 that is air permeable and sample solution impermeable fills in the through hole 341. An optional cap 350 is sized properly to fit to the upper opening 311
  • The porous plug comprises a porous material of the desired property—air permeable and sample solution impermeable. Those of ordinary skill in the art are familiar with materials that may be used to form the porous plastic plug, such as, for example, but not limited to, polyethylene and polytetrafluoroethylene. The median pore size in the porous plastic plug may range from 3 microns to an upper limit which is dependent on the hydrophobicity of the plug material. Air and liquid permeability of porous plugs is related to the pore size and the surface property of the porous material. To achieve the desired property, the pore size of the plug is generally smaller than 30 microns, for example, 10-20 microns. Coating the surface of the porous material with a layer that will melt and forms a gel upon contact with the sample solution is another way to achieve the desired property. Such gel forming material can be selected from a group consisting gum, gelatin, long change polysaccharides, and proteins.
  • The reagent member may comprise more than one test reagent for detecting more than one test substance in the sample solution. For example, the device 300 may contain more than one absorbent test strip each for detecting a different test substance, such as a drug of abuse. When a sample solution, such as a urine specimen, is introduced into the device from the upper opening, the samples flows to the lower section of the device and reacts with the reagents. Therefore, multiple test substances, such as drugs of abuse, can be detected simultaneously. When the liquid level in the lower section of the device reaches the porous plug, the air vent through the plug closes. Additional liquid flow from the upper section to the lower section stops. Such a mechanism forms an automatic control of the volume of liquid flows into the test chamber.
  • The devices of the invention can be used, for example, for testing body fluid samples, environmental samples, stool, and other samples. Substances can be tested using the devices of the invention include drugs of abuse, therapeutic drugs, infectious pathogens, antibodies, blood components, environmental pollutants, such as micro-organisms, explosives, and poisons. The devices of the invention are suitable for testing specimens selected, for example, from the group consisting of stool, blood, urine, and saliva, microbe culture media, and swab specimens of surfaces of an animal, such as the cervix, urethra, nostril, and throat, as well as environmental specimens, such as food products, soil and dust samples. By animal is meant, for example, any live or dead animal including, for example, a mammal, for example, a human. Substances to be tested in these specimens include but are not limited to fecal occult blood components, hapto-hemoglobin complex, antibodies, bacteria, viruses, enzymes, proteins, drugs, substances of abuse, allergens, pesticides, and pollutants.
  • The reagent member can be in liquid, or dry form. In one embodiment of the invention, the reagent member of the test device is a liquid solution comprising reagents capable of reacting with analytes of the sample solution to be tested and produce an assay signal indicative of the presence or quantity of at least one analytes of the sample solution. In another embodiment of the invention, the assay reagent is a dry reagent comprising reagents capable of reacting with analytes of the sample solution to be tested and produce an assay signal indicative of the presence or quantity of at least one analytes of the sample solution. Dry reagents, air-dried or lyophilized, have longer shelf life than liquid reagents. A preferred dry form of assay reagent is, for example, but not limited to, a dry reagent pad, a porous matrix containing the dry assay reagent. Such dry reagents are used for a variety of testing products, such as urine glucose, pH, creatinine, and alcohol test. Another example of a preferred dry reagent member is a lateral flow test strip. Where the reagent member is a dry reagent, for example, a test strip, it is understood by those in the art that the test assembly may comprise more than 1 reagent member, for example, each reagent member comprising reagents for a different analyze detection assay. For example, a device for fecal occult blood test may comprise a reagent member for detecting hemoglobin and another reagent member for detecting hapto-hemoglobin complex.
  • The present invention also provides kits for detecting test substances in solid, semi-solid, or liquid specimens. For example, provided are kits that comprise a device of he present invention. The kits may further comprise instructions for testing for the presence of a substance in a specimen, and may further comprise instructions for obtaining specimen samples. The kits may further comprise reference samples that may be used to compare test results with the specimen samples.
  • Example 1 Test Chamber Device for Fecal Occult Blood Test
  • A fecal occult blood test is an immunoassay based test method for detection of blood in stool specimens. The presence of hemoglobin in feces can be indicative of gastrointestinal tract conditions associated with bleeding such as, for example, colorectal carcinoma, colon polyps, Crohn's disease, and ulcerative colitis. The present example provides a 2-in-1 sample preparation and test device, that does not require liquid pipetting or transfer of the sample or sample solution. A fecal sample is collected and prepared for testing using the fecal collection probe, or sample stick, attached to the cap of the test assembly of the invention. The collection probe is inserted into a fecal specimen at several different sites. Excess sample is removed from the stick by gentle wiping with an absorbent tissue. The probe is reinserted into the tube and the cap is tightened securely. The tube is shaken vigorously to obtain a liquid suspension of the sample. Holding the tube upright, the bottom part of the chamber assembly is loosened about 1 revolution (360°). This allows the sample solution inside of the sample receiving chamber to flow into the test chamber. The device is kept in an upright position for 5 minutes, after which time the results may be read. Waiting for more than 10 minutes may cause the reading to be inaccurate. A negative test is indicated when one rose-pink color band appears in the control zone, meaning that the fecal sample does not contain a detectable level of human hemoglobin. A positive test is indicated when two rose-pink color bands appear, one in the test (T) zone and one in the control (c) zone, A positive result indicates that the specimen contains human hemoglobin. An invalid test is indicated where after five minutes, no bands appear, or a test band appears without a control band appearing.
  • The entirety of each patent, patent application, publication and document referenced herein hereby is incorporated by reference. Citation of the above patents, latent applications, publications and documents is not an admission that any of the foregoing is pertinent prior art, nor does it constitute any admission as to the contents or date of these publications or documents.
  • Singular forms “a”, “an”, and “the” include plural reference unless the context clearly dictates otherwise. Thus, for example, reference to “a subset” includes a plurality of such subsets. Reference to “a nucleic acid” includes one or more nucleic acids and equivalents thereof known to those skilled in the art, and so forth. The term “or” is not meant to be exclusive to one or the terms it designates. For example, as it is used in a phrase of the structure “A or B” may denote A alone, B alone, or both A and B.
  • Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and systems similar or equivalent to those described herein can be used in the practice or testing of the present invention, the methods, devices, and materials are now described. All publications mentioned herein are incorporated herein by reference for the purpose of describing and disclosing the processes, systems, and methodologies which are reported in the publications which might be used in connection with the invention. Nothing herein is to be construed as an admission that the invention is not entitled to antedate such disclosure by virtue of prior invention.
  • Modifications may be made to the foregoing without departing from the basic aspects of the invention. Although the invention has been described in substantial detail with reference to one or more specific embodiments, those of ordinary skill in the art will recognize that changes may be made to the embodiments specifically disclosed in this application, and yet these modifications and improvements are within the scope and spirit of the invention. The invention illustratively described herein suitably may be practiced in the absence of any element(s) not specifically disclosed herein. Thus, for example, in each instance herein any of the terms “comprising”, “consisting essentially of”, and “consisting of may be replaced with either of the other two terms. Thus, the terms and expressions which have been employed are used as terms of description and not of limitation, equivalents of the features shown and described, or portions thereof, are not excluded, and it is recognized that various modifications are possible within the scope of the invention. Embodiments of the invention are set forth in the following claims.

Claims (12)

1. A device for testing a specimen, comprising:
(a) a test assembly comprising
(i) a sample receiving chamber;
(ii) a test chamber;
(iii) a septum wall separating the sample receiving chamber and the test chamber;
(iv) an opening in the septum wall so that the sample receiving chamber and the test area are in fluid communication;
(v) a reagent member positioned in the test chamber, the reagent member having a wick on and a test area comprising at least one assay reagent;
(vi) a breakable seal for preventing flow of the sample from the sample receiving chamber to the test chamber; and
(viii) means for breaking the seal and allowing the sample to flow from the sample receiving chamber to the test chamber.
2. The device of claim 1, where the sample receiving chamber includes a test buffer.
3. The device of claim 1, where the means for breaking the seal is attached to a lower end of the le receiving chamber.
4. The device of claim 1, where the test assembly is formed of a plastic selected from the group sting of polyethylene, polypropylene, polystyrene polyvinyl, and acrylonitrile butadiene styrene.
5. The device of claim 1, further comprising:
(b) a cap including a handle and an insert section sized to fit within an upper end of the test assembly.
6. The device of claim 1, where the reagent member is a lateral flow test strip.
7. The device of claim 1, comprising at least two reagent members.
8. The device of claim 1, comprising from 3-5 reagent members.
9. The device of claim 1, where the assay reagent detects hemoglobin.
10. The device of claim 1, where the assay reagent detects a hapto-hemoglobin complex.
11. A method of using the device of claim 1, comprising:
introducing a sample solution into the sample receiving chamber; mixing the sample with a buffer in the sample receiving chamber; breaking the seal;
introducing the sample into the test chamber through the opening; and
reacting the sample with the assay reagent of the reagent member.
12. The method of claim 11, where said device further includes a cap including a handle and an t sized to fit within an upper end of the test assembly, the method further comprising:
lowering the handle such that the insert section is inserted into the test assembly to move the means for breaking the seal to break the seal.
US12/938,331 2006-01-23 2010-11-02 Rapid Test Apparatus Abandoned US20120164751A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/938,331 US20120164751A1 (en) 2006-01-23 2010-11-02 Rapid Test Apparatus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76158006P 2006-01-23 2006-01-23
US11/625,813 US7871568B2 (en) 2006-01-23 2007-01-22 Rapid test apparatus
US12/938,331 US20120164751A1 (en) 2006-01-23 2010-11-02 Rapid Test Apparatus

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/625,813 Continuation US7871568B2 (en) 2006-01-23 2007-01-22 Rapid test apparatus

Publications (1)

Publication Number Publication Date
US20120164751A1 true US20120164751A1 (en) 2012-06-28

Family

ID=38309779

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/625,813 Expired - Fee Related US7871568B2 (en) 2006-01-23 2007-01-22 Rapid test apparatus
US12/938,331 Abandoned US20120164751A1 (en) 2006-01-23 2010-11-02 Rapid Test Apparatus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/625,813 Expired - Fee Related US7871568B2 (en) 2006-01-23 2007-01-22 Rapid test apparatus

Country Status (7)

Country Link
US (2) US7871568B2 (en)
EP (1) EP1979468A2 (en)
JP (1) JP2009524063A (en)
CN (1) CN102621295B (en)
AU (1) AU2007208334B2 (en)
CA (1) CA2639957C (en)
WO (1) WO2007087261A2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110000322A1 (en) * 2008-03-04 2011-01-06 Novast Holding Limited Sampling tools for powder
US20180325497A1 (en) * 2015-11-09 2018-11-15 Novamed Ltd. Body liquids collection and diagnostic device
WO2018217184A1 (en) * 2017-05-20 2018-11-29 Sandstone Diagnostics, Inc. Specimen cup
US10197480B2 (en) 2012-11-07 2019-02-05 Sandstone Diagnostics, Inc. Methods and devices for processing samples and counting cells
US10376877B2 (en) 2013-02-07 2019-08-13 Sandstone Diagnostics, Inc. Automated sample processing, fluid distribution, and sedimentation assay
EP3726216A4 (en) * 2017-12-28 2021-09-15 Icst Corporation Test device and test method
US11714034B2 (en) 2012-11-07 2023-08-01 Laboratory Corporation Of America Holdings Methods and devices for processing samples and counting cells

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7871568B2 (en) 2006-01-23 2011-01-18 Quidel Corporation Rapid test apparatus
US7794656B2 (en) 2006-01-23 2010-09-14 Quidel Corporation Device for handling and analysis of a biological sample
US20090215159A1 (en) * 2006-01-23 2009-08-27 Quidel Corporation Device for handling and analysis of a biological sample
CN201096654Y (en) * 2007-06-28 2008-08-06 万华普曼生物工程有限公司 A novel urine collector
US7981054B2 (en) * 2007-07-16 2011-07-19 Phuong Nguyen All-in-one biological specimen collecting, transporting and analyzing device
JP4953980B2 (en) * 2007-08-20 2012-06-13 株式会社アトレータ Urine collection container
AU2008316775B2 (en) 2007-10-23 2011-12-08 Becton, Dickinson And Company Closed kit for tissue containment and stabilization for molecular and histopathology diagnostics
MX2010004427A (en) 2007-10-23 2010-05-03 Becton Dickinson Co Tissue container for molecular and histology diagnostics incorporating a breakable membrane.
US7927562B2 (en) * 2007-12-13 2011-04-19 W.H.P.M. Inc. Collection and assay device for biological fluid
DE102008023545A1 (en) * 2008-05-14 2009-11-19 Roderfeld Und Bora Gmbh & Co.Kg Device for producing a biologically active substance
WO2010001296A1 (en) 2008-07-04 2010-01-07 Koninklijke Philips Electronics N. V. Sampling device and sampling method
BRPI0913733A2 (en) * 2008-09-30 2015-08-18 3M Innovative Properties Co Cell Detection Items, Sample Acquisition Device, Cell Detection Kit and Methods
US8137956B2 (en) * 2008-11-14 2012-03-20 Stephen Patrick Ashburn Forensic test strip and method for the detection of semen
FR2940011B1 (en) * 2008-12-19 2014-11-28 Allflex Europe DEVICE FOR TAKING ANIMAL TISSUE AND CORRESPONDING MEANS OF STORAGE
CN102439445A (en) * 2009-01-16 2012-05-02 理德免疫诊断有限责任公司 Detection devices and methods
DE102009007616A1 (en) * 2009-02-05 2010-08-12 Gaudlitz Gmbh Test device for liquids of the human or animal body
WO2010132453A2 (en) * 2009-05-11 2010-11-18 Nexus Dx, Inc. Methods and compositions for analyte detection
FR2961087B1 (en) 2010-06-09 2013-06-28 Allflex Europ TOOL FOR SAMPLING AN ANIMAL TISSUE SAMPLE.
FR2963203B1 (en) 2010-07-30 2013-11-15 Allflex Europ MARKING AND / OR ANIMAL TISSUE COLLECTION ASSEMBLY AND CORRESPONDING MARKING AND / OR LEANING TOOL.
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
US9404910B2 (en) * 2010-11-12 2016-08-02 W.H.P.M. Bioresearch & Technology Co., Ltd. Body fluid testing apparatus with testing and storing functions
CN102087295B (en) * 2011-01-24 2013-04-03 杭州安旭科技有限公司 Rapid detecting device
EP2745119B1 (en) * 2011-08-16 2018-04-25 Exact Sciences Corporation Sample collection device
US9234887B2 (en) 2011-09-28 2016-01-12 Power Fit S.R.L. Measurement of lactic acid in biological fluids
US9381524B2 (en) 2011-11-08 2016-07-05 Becton, Dickinson And Company System and method for automated sample preparation
US9075039B2 (en) 2011-11-08 2015-07-07 Becton, Dickinson And Company Container and cap for a biological specimen
EP2617362B1 (en) 2012-01-20 2019-04-10 Bühlmann Laboratories AG Sample extracting, diluting and discharging device
CN102564796A (en) * 2012-02-24 2012-07-11 万华普曼生物工程有限公司 Excrement collector
CN102768206A (en) * 2012-07-03 2012-11-07 万华普曼生物工程有限公司 Body fluid detection device
US9149807B2 (en) 2012-08-20 2015-10-06 Berlin Packaging, Llc Specimen test unit
CN102798542B (en) * 2012-08-22 2014-06-18 浙江大学 Device for stool sampling and occult blood self-detection
EP2934338A1 (en) * 2012-12-22 2015-10-28 Frost Diagnostika GmbH Device for removing and preparing a sample
US10195610B2 (en) 2014-03-10 2019-02-05 Click Diagnostics, Inc. Cartridge-based thermocycler
US9091680B1 (en) 2014-05-20 2015-07-28 Robert Schreiber Fecal occult blood testing system
JP6248833B2 (en) * 2014-07-07 2017-12-20 株式会社島津製作所 Stool collection container
ES2898103T3 (en) 2014-12-31 2022-03-03 Visby Medical Inc Devices for molecular diagnostic tests
US20160305954A1 (en) * 2015-04-17 2016-10-20 Kenneth Davin Fine Diagnostic testing for immunologic food sensitivity
CN104792567B (en) * 2015-04-30 2018-03-02 珠海市银科医学工程有限公司 It is a kind of new to adopt just and tachysynthesis detection means and its operating method
CN104849440B (en) 2015-05-28 2017-07-11 万华普曼生物工程有限公司 Acquisition testing integrated device with anti-error assembling structure
EP3392639A4 (en) * 2015-12-16 2019-08-07 Kyowa Medex Co., Ltd. Stool collecting unit, method for measuring components in stool sample, method for stabilizing components in stool sample, and method for storing stool sample
CN105547736B (en) * 2016-01-21 2018-07-10 浙江东方基因生物制品有限公司 A kind of efficient and environment-friendly type stool drawing device
US10987674B2 (en) 2016-04-22 2021-04-27 Visby Medical, Inc. Printed circuit board heater for an amplification module
WO2017197040A1 (en) 2016-05-11 2017-11-16 Click Diagnostics, Inc. Devices and methods for nucleic acid extraction
US10222371B1 (en) * 2016-06-21 2019-03-05 Nano 2.0 Business Press, Llc Lateral flow assay contained within a biopsy specimen collection bottle for qualitative visual detection of protein present in biopsy samples
USD800331S1 (en) 2016-06-29 2017-10-17 Click Diagnostics, Inc. Molecular diagnostic device
WO2018005710A1 (en) 2016-06-29 2018-01-04 Click Diagnostics, Inc. Devices and methods for the detection of molecules using a flow cell
USD800913S1 (en) 2016-06-30 2017-10-24 Click Diagnostics, Inc. Detection window for molecular diagnostic device
USD800914S1 (en) 2016-06-30 2017-10-24 Click Diagnostics, Inc. Status indicator for molecular diagnostic device
CN106706625A (en) * 2017-01-19 2017-05-24 丁葆兰 Disposable intestinal tumor screening detection cannula
CN106680477B (en) * 2017-02-14 2019-03-01 杭州诺辉健康科技有限公司 It a kind of stool sampling and occults blood and detects integrated apparatus
US20210146352A1 (en) * 2017-07-24 2021-05-20 Epitope Diagnostics, Inc. Fecal sample collection and analyte extraction device and method
CN111655866A (en) 2017-11-09 2020-09-11 维斯比医学公司 Portable molecular diagnostic device and method for detecting target virus
CN110018013A (en) * 2019-03-27 2019-07-16 江苏宝卫士生物科技有限公司 A kind of Medical sampling, detection integrated apparatus
IL268395A (en) * 2019-07-31 2021-01-31 Katz Emil A system and method for collecting, sampling, culturing, and inspecting fluids
CA3089520A1 (en) * 2019-08-08 2021-02-08 American Laboratory Products Company, Ltd. Extraction device and related method for sampling material
USD940893S1 (en) * 2019-08-08 2022-01-11 American Laboratory Products Company, Ltd. Extraction device
EP4125614A1 (en) * 2020-03-27 2023-02-08 Marshall Venture Partners LLC Systems and methods for fluid sample collection and testing using a swab assembly with integral lateral flow test strips
AU2021297973A1 (en) * 2020-06-24 2023-01-19 President And Fellows Of Harvard College Automatic multi-step reaction device
CN113049575B (en) * 2021-02-23 2023-05-16 深圳职业技术学院 Medicine detection device and system
WO2022232056A1 (en) * 2021-04-26 2022-11-03 Chan Zuckerberg Biohub, Inc. Testing devices
CN113358640B (en) * 2021-07-29 2022-11-11 新乡医学院 Kit for early screening of rectal cancer and screening method thereof
KR102333133B1 (en) 2021-07-29 2021-12-02 한경준 All in one self checking kit
CA3230713A1 (en) * 2021-09-08 2023-03-16 Thomas E. Schaus Systems and methods for controlling fluid flow between multiple chambers of a testing device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277646B1 (en) * 1997-05-05 2001-08-21 Dade Behring Inc. Fluid specimen collecting and testing apparatus
US20040060374A1 (en) * 2002-07-19 2004-04-01 Goodin John W. Spill proof liquid sample cup
US20050112024A1 (en) * 2003-11-14 2005-05-26 Lijian Guo Sample collection cup with integrated activatable sample analysis system
US20060148096A1 (en) * 2002-11-05 2006-07-06 Jina Arvind N Assay device, system and method
US7871568B2 (en) * 2006-01-23 2011-01-18 Quidel Corporation Rapid test apparatus

Family Cites Families (170)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) * 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US3660033A (en) * 1969-09-29 1972-05-02 Leroy L Schwartz Disposable specimen collection and analysis bag
US3992158A (en) 1973-08-16 1976-11-16 Eastman Kodak Company Integral analytical element
US4275149A (en) * 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4299916A (en) 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
NL8000173A (en) * 1980-01-11 1981-08-03 Akzo Nv USE OF WATER-DISPERSIBLE HYDROPHOBIC DYES AS LABELS IN IMMUNOCHEMICAL TESTS.
US6406920B1 (en) * 1980-06-20 2002-06-18 Inverness Medical Switzerland Gmbh Processes and apparatus for carrying out specific binding assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4426451A (en) * 1981-01-28 1984-01-17 Eastman Kodak Company Multi-zoned reaction vessel having pressure-actuatable control means between zones
DE3118381A1 (en) * 1981-05-09 1982-11-25 Boehringer Mannheim Gmbh, 6800 Mannheim MULTILAYER TEST MEANS FOR DETECTING A COMPONENT OF A LIQUID SAMPLE
US4353868A (en) * 1981-05-29 1982-10-12 Sherwood Medical Industries Inc. Specimen collecting device
US4695554A (en) 1984-02-14 1987-09-22 Becton Dickinson And Company Sac or liposome containing dye (sulforhodamine) for immunoassay
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US4945205A (en) * 1984-04-12 1990-07-31 Syntex (U.S.A.) Inc. Chromatographic strip having non-compressed edges
US4632901A (en) 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
US4999285A (en) * 1984-11-15 1991-03-12 Syntex (U.S.A.) Inc. Chromatographic cassette
US4863875A (en) 1985-08-26 1989-09-05 Gia Research Company, L.P. Dye labelled antibodies as reagents for use in immunoassay systems
DE8524541U1 (en) 1985-08-28 1985-10-17 Lenhardt, Karl, 7531 Neuhausen Device for drying washed glass sheets
US4806311A (en) * 1985-08-28 1989-02-21 Miles Inc. Multizone analytical element having labeled reagent concentration zone
TW203120B (en) * 1985-10-04 1993-04-01 Abbott Lab
DE3540526A1 (en) * 1985-11-15 1987-05-27 Bayer Ag TRANSPARENT TEST STRIP SYSTEM
US4643560A (en) * 1985-11-27 1987-02-17 Eastman Kodak Company Apparatus and method for synchronizing exposure of a document onto a photosensitive member
US5160701A (en) 1986-02-18 1992-11-03 Abbott Laboratories Solid-phase analytical device and method for using same
US4916056A (en) * 1986-02-18 1990-04-10 Abbott Laboratories Solid-phase analytical device and method for using same
AU7385687A (en) 1986-06-09 1987-12-10 Ortho Diagnostic Systems Inc. Immunoglobulin immunoassay with internalized control assays
US5514602A (en) 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
AU7385387A (en) 1986-06-09 1987-12-10 Ortho Diagnostic Systems Inc. Immunoassay using detection of colloidal gold
US5763262A (en) * 1986-09-18 1998-06-09 Quidel Corporation Immunodiagnostic device
DE3782597T3 (en) 1986-09-18 2002-09-05 Pacific Biotech Inc Immunodiagnostic device.
CA1303983C (en) * 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
USRE38430E1 (en) * 1987-03-27 2004-02-17 Becton, Dickinson And Company Solid phase chromatographic immunoassay
ES2050704T5 (en) 1987-04-27 2004-04-16 Inverness Medical Switzerland Gmbh IMMUNOENSAYS AND DEVICES FOR THEIR REALIZATION.
US4943522A (en) * 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
US5275785A (en) * 1987-10-30 1994-01-04 Unilever Patent Holdings B.V. Test device for detecting an analyte in a liquid sample
FR2622435B1 (en) 1987-10-30 1990-03-09 Nigay Pierre RECEPTACLE OF URINE AND SADDLE
US5334513A (en) * 1988-05-17 1994-08-02 Syntex (U.S.A.) Inc. Method for immunochromatographic analysis
US5039607A (en) 1988-05-17 1991-08-13 Syntex (U.S.A.) Inc. Method for immunochromatographic analysis
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
DE3826057A1 (en) * 1988-07-30 1990-02-01 Boehringer Mannheim Gmbh TEST TESTER FOR THE ANALYTICAL DETERMINATION OF AN INGREDIENT OF A LIQUID SAMPLE
US5338513A (en) * 1988-07-30 1994-08-16 Boehringer Mannheim Gmbh Test carrier for the analytical determination of a component of a liquid sample
IT1227293B (en) 1988-10-06 1991-04-05 Boehringer Biochemia Srl DEVICE AND METHOD FOR PREGNANCY DIAGNOSIS
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
US5075078A (en) 1989-10-05 1991-12-24 Abbott Laboratories Self-performing immunochromatographic device
US5096837A (en) * 1990-02-08 1992-03-17 Pacific Biotech, Inc. Immunochromatographic assay and method of using same
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US5223220A (en) * 1990-03-27 1993-06-29 Pacific Biotech, Inc. Solid phase immunoassay device and method of making same
US5266497A (en) 1990-08-31 1993-11-30 Japan Synthetic Rubber Co., Ltd. Immunochromatographic assay with improved colored latex
US5283038A (en) * 1990-12-18 1994-02-01 Saliva Diagnostic Systems, Inc. Fluid sampling and testing device
US5268148A (en) * 1990-12-18 1993-12-07 Saliva Diagnostic Systems, Inc. Saliva sampling device and sample adequacy system
DE69229334T2 (en) * 1991-01-11 1999-12-16 Quidel Corp ONE-STAGE CROSS-FLOW ANALYZING METHOD AND A NON-SUCTIONABLE CARRIER USED IN IT
US5208166A (en) * 1991-02-28 1993-05-04 Saunders Mary S Reactive chitosan coated articles and test kit for immunoassay
JP3108115B2 (en) * 1991-03-28 2000-11-13 ロート製薬株式会社 Substance detection method by immunochromatography
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5877028A (en) 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
DE69219686T2 (en) * 1991-07-29 1997-09-11 Mochida Pharm Co Ltd Method and device for use in specific binding tests
US5160021A (en) 1991-07-30 1992-11-03 Barry Sibley Leak-proof cylindrical container for the transport of diagnostic specimens or dangerous substances
US5726010A (en) * 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6100099A (en) * 1994-09-06 2000-08-08 Abbott Laboratories Test strip having a diagonal array of capture spots
JP2733639B2 (en) * 1992-04-22 1998-03-30 日本商事株式会社 Sample container
US6767510B1 (en) * 1992-05-21 2004-07-27 Biosite, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6156270A (en) 1992-05-21 2000-12-05 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5458852A (en) 1992-05-21 1995-10-17 Biosite Diagnostics, Inc. Diagnostic devices for the controlled movement of reagents without membranes
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US6905882B2 (en) 1992-05-21 2005-06-14 Biosite, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6019944A (en) * 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5356782A (en) 1992-09-03 1994-10-18 Boehringer Mannheim Corporation Analytical test apparatus with on board negative and positive control
FI92882C (en) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Disposable test strip and process for its manufacture
US5415994A (en) * 1993-08-02 1995-05-16 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
JPH07120460A (en) * 1993-10-28 1995-05-12 Dainippon Printing Co Ltd Detection device for occult blood in stool
DK0653639T3 (en) * 1993-11-12 2000-07-24 Unilever Nv Analytical devices and methods for their use
DE69405116T2 (en) 1993-11-12 1998-03-05 Unipath Ltd DETECTION DEVICE AND PRODUCTION METHOD THEREFOR
US5521102A (en) * 1994-08-08 1996-05-28 Quidel Corporation Controlled sensitivity immunochromatographic assay
US6686170B1 (en) * 1994-08-17 2004-02-03 Abbott Laboratories Assay devices with mobile control reagents
GB9419267D0 (en) * 1994-09-23 1994-11-09 Unilever Plc Assay devices
US5882942A (en) * 1995-02-15 1999-03-16 Wako Pure Chemical Industries, Ltd. Method for sampling feces
US5712172A (en) * 1995-05-18 1998-01-27 Wyntek Diagnostics, Inc. One step immunochromatographic device and method of use
US6486231B1 (en) * 1995-04-19 2002-11-26 Csp Technologies, Inc. Co-continuous interconnecting channel morphology composition
US6613405B1 (en) 1995-04-19 2003-09-02 Csp Technologies, Inc. Monolithic composition having the capability of maintaining constant relative humidity in a package
DE19514708C1 (en) * 1995-04-21 1996-08-08 Kostal Leopold Gmbh & Co Kg Rotationally symmetric electric switch influenced by permanent magnets
US5804452A (en) 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
US5786220A (en) 1995-04-28 1998-07-28 Quidel Corporation Assays and devices for distinguishing between normal and abnormal pregnancy
US5827675A (en) * 1995-07-12 1998-10-27 Charm Sciences, Inc. Test apparatus, system and method for the detection of test samples
CA2228485A1 (en) 1995-08-03 1997-02-20 Akzo Nobel Nv Diagnostic device
US5773234A (en) * 1995-08-07 1998-06-30 Quidel Corporation Method and device for chlamydia detection
WO1997006439A1 (en) 1995-08-09 1997-02-20 Quidel Corporation Test strip and method for one step lateral flow assay
JP3487683B2 (en) * 1995-08-28 2004-01-19 積水化学工業株式会社 Fecal occult blood determination device
US5800779A (en) 1995-11-20 1998-09-01 Johnson; Theodore D. Diagnostic sampling device and system for analyzing body fluids
US6057166A (en) * 1995-12-22 2000-05-02 Universal Healthwatch, Inc. Fecal test method
US5776896A (en) * 1996-01-03 1998-07-07 Zeneca Limited Analgesic peptides from venom of grammostola spatulata and use thereof
IT1281738B1 (en) 1996-01-17 1998-02-27 Boehringer Mannheim Italia DEVICE FOR PERFORMING RAPID DIAGNOSTIC TESTS ON LIQUID SAMPLES
US5962333A (en) 1996-01-25 1999-10-05 Multisorb Technologies, Inc. Medical diagnostic test strip with desiccant
JP3026549B2 (en) 1996-05-02 2000-03-27 ダイナボット株式会社 Manufacturing method of chromatography immunoanalyzer
WO1997044664A1 (en) 1996-05-23 1997-11-27 Unilever Plc Improvements in or relating to specific binding assays
US5788220A (en) * 1996-06-14 1998-08-04 Meziere, Sr.; Gary C. Linearly actuated gas flow control assembly
TW565614B (en) * 1996-07-18 2003-12-11 Univ Australian Detection of mammalian heparanase activity and purification of mammalian heparanase
US6391265B1 (en) * 1996-08-26 2002-05-21 Biosite Diagnostics, Inc. Devices incorporating filters for filtering fluid samples
EP0833157B1 (en) 1996-09-27 2002-11-20 Inverness Medical Switzerland GmbH Assay reagents and devices
US6165798A (en) 1996-10-10 2000-12-26 University Of British Columbia Optical quantification of analytes in membranes
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US6194221B1 (en) * 1996-11-19 2001-02-27 Wyntek Diagnostics, Inc. Hybrid one-step immunochromatographic device and method of use
US6924153B1 (en) 1997-03-06 2005-08-02 Quidel Corporation Quantitative lateral flow assays and devices
GB9709821D0 (en) * 1997-05-15 1997-07-09 Clinical Diagnostic Chemicals Allergy assay
GB2326712B (en) 1997-06-25 2001-09-26 Fujirebio Kk Colour devoloping method,enzyme immunoassay using the colour developing method,and immunochromatography incorporating the enzyme immunoassay
US5895765A (en) * 1997-06-30 1999-04-20 Bayer Corporation Method for the detection of an analyte by immunochromatography
KR100292182B1 (en) 1997-09-18 2001-11-26 모리시타 요이찌 Immunochromatography Devices
HUP0102458A2 (en) 1997-11-05 2001-11-28 American Bio Medica Corporation Device for the testing of fluid samples and process for making the device
US6087184A (en) * 1997-11-10 2000-07-11 Beckman Coulter, Inc. Opposable-element chromatographic assay device for detection of analytes
US6120733A (en) * 1997-11-12 2000-09-19 Goodman; David B. P. Self-contained assay device
US6306642B1 (en) 1997-11-24 2001-10-23 Quidel Corporation Enzyme substrate delivery and product registration in one step enzyme immunoassays
US6194222B1 (en) 1998-01-05 2001-02-27 Biosite Diagnostics, Inc. Methods for monitoring the status of assays and immunoassays
US6178369B1 (en) * 1998-01-30 2001-01-23 Continental Teves Ag & Co., Ohg Method and regulating system for applying defined actuating forces
US6537505B1 (en) * 1998-02-20 2003-03-25 Bio Dot, Inc. Reagent dispensing valve
WO1999046591A2 (en) 1998-03-10 1999-09-16 Strategic Diagnostics, Inc. Integrated assay device and methods of production and use
WO1999047930A1 (en) 1998-03-16 1999-09-23 Quidel Corporation Immunoassay device and method
US6248294B1 (en) * 1998-04-15 2001-06-19 Frederic L. Nason Self contained diagnostic test unit
AUPP323798A0 (en) 1998-04-28 1998-05-21 Chandler, Howard Milne Sample collection method
SE9801563D0 (en) * 1998-04-30 1998-04-30 Pharmacia & Upjohn Diag Ab Method of separation and kit to be used in the process
US6270040B1 (en) * 2000-04-03 2001-08-07 Kam Industries Model train control system
DE19830405C2 (en) * 1998-07-08 2000-09-21 Draeger Sicherheitstech Gmbh Test strips for immunochemical substance detection
CA2270797A1 (en) * 1998-07-27 2000-01-27 Bayer Corporation Transparent flow through membrane for dry reagent analytical devices
US6410341B1 (en) * 1998-08-06 2002-06-25 Spectral Diagnostics, Inc. Analytical test device and method for use in medical diagnoses
KR100604510B1 (en) * 1998-08-06 2006-07-25 스펙트랄 다이아그나스틱스, 인크. Analytical test device and method
US6730494B1 (en) * 1999-09-17 2004-05-04 Guardian Angel Holdings, Inc. Alcohol concentration test delivery system
US6284198B1 (en) 1998-09-30 2001-09-04 K&M Environmental Inc. Self appearing warning sign device and method of manufacture
US6187369B1 (en) 1998-11-12 2001-02-13 Biocoat Incorporated Hydrophilic substrates and method of making same
US6379620B1 (en) * 1998-11-16 2002-04-30 Barry M. Tydings Assaying device and method for in field urinalysis
US6109943A (en) * 1999-04-15 2000-08-29 Lucent Technologies Inc. Selectable compatibility electrical connector plug
US6180417B1 (en) 1999-04-22 2001-01-30 Bayer Corporation Immunochromatographic assay
JP4139022B2 (en) * 1999-10-15 2008-08-27 東京電力株式会社 How to remove external noise
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
US20020004246A1 (en) 2000-02-07 2002-01-10 Daniels Robert H. Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels
US6548018B2 (en) * 2000-03-31 2003-04-15 Neogen Corporation Apparatus for chemiluminescent assays
US6699722B2 (en) * 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
US6436722B1 (en) * 2000-04-18 2002-08-20 Idexx Laboratories, Inc. Device and method for integrated diagnostics with multiple independent flow paths
US6656745B1 (en) 2000-06-02 2003-12-02 Francis X. Cole Devices and methods for a multi-level, semi-quantitative immunodiffusion assay
US6488828B1 (en) 2000-07-20 2002-12-03 Roche Diagnostics Corporation Recloseable biosensor
CA2426246A1 (en) * 2000-10-18 2002-04-25 Clarity Technologies Incorporated Method and device for diluting a fluid and detecting analytes within a diluted fluid
US20020098532A1 (en) * 2000-12-01 2002-07-25 Yee Hsian Chiang One step test for abortion safety based on detection of 2 IU/ml or more of gonadtropin in a urine sample
US6558528B1 (en) 2000-12-20 2003-05-06 Lifescan, Inc. Electrochemical test strip cards that include an integral dessicant
DE10065474C1 (en) * 2000-12-28 2002-06-06 Bosch Gmbh Robert Fuel metering control method for turbocharged IC engine, fuel injection has replacement main control value provided when leak is detected in engine air intake
US6726879B2 (en) * 2001-05-21 2004-04-27 Ameditech, Inc. Dual chambered fluid specimen testing device and method
US6855561B2 (en) * 2001-09-10 2005-02-15 Quidel Corporation Method for adding an apparent non-signal line to a lateral flow assay
JP4320255B2 (en) * 2001-09-26 2009-08-26 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト Portable instrument for collecting body fluids
EP1451560B1 (en) 2001-12-06 2017-11-29 BioControl Systems, Inc. Sample collection and testing system
EP1327884B1 (en) 2002-01-09 2009-07-29 Inverness Medical Switzerland GmbH Reagent test strip comprising control means and timer means
US20030161762A1 (en) 2002-02-08 2003-08-28 Michael Caron Instrument for determining concentration of multiple analytes in a fluid sample
EP1376131A1 (en) 2002-06-27 2004-01-02 Inverness Medical Switzerland GmbH Assay device for liquid sample
US6921370B2 (en) * 2002-07-25 2005-07-26 Alfa Scientific Designs, Inc. Specimen collection and storage and transport device and method
US6780160B2 (en) * 2002-07-25 2004-08-24 Akfa Scientific Designs, Inc. Specimen collection and application apparatus
US7323139B2 (en) 2002-07-26 2008-01-29 Quantum Design, Inc. Accessible assay and method of use
US6944142B2 (en) * 2003-05-13 2005-09-13 Interdigital Technology Corporation Method for soft and softer handover in time division duplex code division multiple access (TDD-CDMA) networks
GB2404735A (en) * 2003-08-05 2005-02-09 Harjinder Singh Dau Apparatus for analysing fluids e.g. urine
US7517495B2 (en) * 2003-08-25 2009-04-14 Inverness Medical Switzerland Gmbh Biological specimen collection and analysis system
US20050119589A1 (en) * 2003-11-14 2005-06-02 Tung Hsiaoho E. Rapid sample collection and analysis device and methods of use
US7052651B2 (en) * 2004-01-26 2006-05-30 Alfa Scientific Designs, Inc. Disposable immunoassay sample-collector and chromatographic-testing device
JP2007530946A (en) 2004-03-23 2007-11-01 クイデル コーポレイション Hybrid phase lateral flow assay
PL1754971T3 (en) 2004-04-30 2008-12-31 Certest Biotec S L Rapid diagnostic strip comprising a moisture-absorbing material and the blister packaging thereof
DE102004033317A1 (en) 2004-07-09 2006-02-09 Roche Diagnostics Gmbh Analytical test element
US7758815B2 (en) * 2004-08-03 2010-07-20 Hartselle R Lawrence Specimen collection, storage, transportation and assaying device
US20060062690A1 (en) * 2004-08-17 2006-03-23 Polymer Technology Systems, Inc. Apparatus and method of manufacturing bodily fluid test strip
EP1802974B1 (en) 2004-09-30 2009-01-07 Quidel Corporation Analytical devices with primary and secondary flow paths
US20060210448A1 (en) * 2005-03-10 2006-09-21 Naishu Wang Fecal specimen collection, preserving and transport device and method
US20070065339A1 (en) * 2005-09-22 2007-03-22 Blane Huff Urine collection and drug testing cup
CN100478671C (en) * 2005-10-25 2009-04-15 艾康生物技术(杭州)有限公司 Detector and method for liquid sampler
US7794656B2 (en) * 2006-01-23 2010-09-14 Quidel Corporation Device for handling and analysis of a biological sample
ES2433377T3 (en) 2006-02-21 2013-12-10 Nexus Dx, Inc. Procedures and compositions for the detection of analytes
JP4876646B2 (en) 2006-03-13 2012-02-15 富士レビオ株式会社 Immunoassay strip and immunoassay device
US20080019867A1 (en) * 2006-07-22 2008-01-24 Johnson Paul K Urinalysis screening device
US7981054B2 (en) 2007-07-16 2011-07-19 Phuong Nguyen All-in-one biological specimen collecting, transporting and analyzing device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277646B1 (en) * 1997-05-05 2001-08-21 Dade Behring Inc. Fluid specimen collecting and testing apparatus
US20040060374A1 (en) * 2002-07-19 2004-04-01 Goodin John W. Spill proof liquid sample cup
US20060148096A1 (en) * 2002-11-05 2006-07-06 Jina Arvind N Assay device, system and method
US20050112024A1 (en) * 2003-11-14 2005-05-26 Lijian Guo Sample collection cup with integrated activatable sample analysis system
US7871568B2 (en) * 2006-01-23 2011-01-18 Quidel Corporation Rapid test apparatus

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110000322A1 (en) * 2008-03-04 2011-01-06 Novast Holding Limited Sampling tools for powder
US10197480B2 (en) 2012-11-07 2019-02-05 Sandstone Diagnostics, Inc. Methods and devices for processing samples and counting cells
US11714034B2 (en) 2012-11-07 2023-08-01 Laboratory Corporation Of America Holdings Methods and devices for processing samples and counting cells
US10376877B2 (en) 2013-02-07 2019-08-13 Sandstone Diagnostics, Inc. Automated sample processing, fluid distribution, and sedimentation assay
US11471881B2 (en) 2013-02-07 2022-10-18 Laboratory Corporation Of America Holdings Automated sample processing, fluid distribution, and sedimentation assay
US20180325497A1 (en) * 2015-11-09 2018-11-15 Novamed Ltd. Body liquids collection and diagnostic device
US10993705B2 (en) * 2015-11-09 2021-05-04 Novamed Ltd. Body liquids collection and diagnostic device
WO2018217184A1 (en) * 2017-05-20 2018-11-29 Sandstone Diagnostics, Inc. Specimen cup
US10870109B2 (en) 2017-05-20 2020-12-22 Sandstone Diagnostics, Inc. Sample cup
EP3726216A4 (en) * 2017-12-28 2021-09-15 Icst Corporation Test device and test method
US11857971B2 (en) 2017-12-28 2024-01-02 Icst Corporation Test device and test method

Also Published As

Publication number Publication date
US7871568B2 (en) 2011-01-18
AU2007208334A1 (en) 2007-08-02
AU2007208334B2 (en) 2012-06-07
JP2009524063A (en) 2009-06-25
CN102621295B (en) 2018-04-27
WO2007087261A3 (en) 2007-11-22
CA2639957A1 (en) 2007-08-02
CN102621295A (en) 2012-08-01
CA2639957C (en) 2017-02-28
US20070275475A1 (en) 2007-11-29
WO2007087261A2 (en) 2007-08-02
EP1979468A2 (en) 2008-10-15

Similar Documents

Publication Publication Date Title
CA2639957C (en) Rapid test apparatus
US20080286831A1 (en) Sample collector and tester
US7794656B2 (en) Device for handling and analysis of a biological sample
US5268148A (en) Saliva sampling device and sample adequacy system
US5393496A (en) Saliva sampling device and sample adequacy system
ES2815828T3 (en) Test device
CN101389965A (en) Rapid test apparatus
US20050106753A1 (en) Sanitary fluid collection, application and storage device and methods of use of same
US20090215159A1 (en) Device for handling and analysis of a biological sample
JP2007511768A (en) Fluid sample analyzer with sealable sample storage reservoir
AU2021200665B2 (en) Device and method for collecting and detecting samples
US20190366326A1 (en) Device for taking a sample and sample analysis system comprising such a device
CN107782575B (en) System and method for collecting and detecting analyzed substance in sample
US20070031914A1 (en) Devices for analyte assays and methods of use
CN111871474A (en) Detachable detection device
US20220323950A1 (en) Blood collection structure and whole blood and fingertip blood testing device and testing method
US20220250053A1 (en) Apparatus and method for collecting and testing sample
CN210401424U (en) Sample collection member
US7863053B2 (en) Swab-based diagnostic systems
WO2022213407A1 (en) Blood collection structure, and whole blood and fingerstick blood detection device and method
CN215078636U (en) Whole blood detection device
CN215078596U (en) Blood sampling structure
CN210514091U (en) Diagnostic reagent sampling and detecting integrated device
CN211122547U (en) Sample collection and detection device
CN210401425U (en) Sample collecting and detecting device

Legal Events

Date Code Title Description
AS Assignment

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, WASHINGTON

Free format text: SECURITY INTEREST;ASSIGNOR:QUIDEL CORPORATION;REEL/FRAME:044141/0686

Effective date: 20171006

Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, WA

Free format text: SECURITY INTEREST;ASSIGNOR:QUIDEL CORPORATION;REEL/FRAME:044141/0686

Effective date: 20171006

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: QUIDEL CORPORATION, CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:060220/0649

Effective date: 20220527